High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases

Israel Medical Association Journal

Volumn 10, Issue 1, 2008, Pages 26-28

  Voll, Reinhard E ^a   Urbonaviciute, Vilma ^a   Hermann, Martin ^a   Kalden, Joachim R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Autoantibodies; Autoimmunity; HMGB1; Inflammation; Nucleosomes; Systemic lupus erythematosus

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ANTIBODY;

ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; NONHUMAN; NUCLEOSOME; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; SKIN LUPUS ERYTHEMATOSUS; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; WESTERN BLOTTING; CHROMATIN; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; METABOLISM; MONOCYTE; NECROSIS; REVIEW;

ANTIBODIES; APOPTOSIS; AUTOIMMUNE DISEASES; CHROMATIN; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MACROPHAGES; MONOCYTES; NECROSIS;

EID: 41149168670     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tsuda K, Kikuchi M, Mori K, Waga S, Yoshida M. Primary structure of non-histone protein HMG1 revealed by the nucleotide sequence. Biochemistry 1988;27:6159-63.
2. Thomas JO, Travers AA. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 2001;6:167-74.
3. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-46.
4. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996;54:35-100.
5. Bianchi ME, Beltrame M, Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science 1989;243:1056-9.
6. Bianchi ME, Falciola L, Ferrari S, Lilley DM. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. Embo J 1992;11:1055-63.
7. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5: 331-42.
8. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1-5.
9. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-51.
10. Chen G, Li J, Ochani M, et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNFdependent mechanisms. J Leukoc Biol 2004;76:994-1001.
11. Rendon-Mitchell B, Ochani M, Li J, et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNFdependent mechanism. J Immunol 2003;170:3890-7.
12. Wang H, Vishnubhakat JM, Bloom O, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999;126:389-92.
13. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418: 191-5.
14. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-7.
15. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-70.
16. Rovere-Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825-30.
17. Kokkola R, Sundberg E, Ulfgren AK, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002;46:2598-603.
18. Taniguchi N, Kawahara K, Yone K, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003;48:971-81.
19. Urbonaviciute V, Furnrohr BG, Weber C, et al. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol 2007;81:67-74.
20. Popovic K, Ek M, Espinosa A, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 2005;52:3639-45.
21. Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 2007;16:794-802.
22. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997; 390:350-1.
23. Fadok VA, McDonald PP, Bratton DL, Henson PM. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans 1998;26:653-6.
24. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
25. Baumann I, Kolowos W, Voll RE, Manger B, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002;46:191-201.
26. Ayer LM, Senecal JL, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group proteins in systemic sclerosis. J Rheumatol 1994;21:2071-5.
27. Rosenberg AM, Cordeiro DM. Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. J Rheumatol 2000;27:2489-93.
28. Sobajima J, Ozaki S, Uesugi H, et al. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin Exp Immunol 1998;111:402-7.